Let employees know: New vaping products far from safe
Cigarette smoking remains the leading cause of preventable disease and death in the United States, claiming more than 480,000 lives each year. There’s a new reason to continue to emphasize smoking cessation as part of your company’s wellness program, however.
New tobacco-like products that encourage young people to vape and expose their lungs to questionable substances are on the market. They are designed to both deliver an addictive chemical into the body and skirt regulations.
Exempt from regulations?
The Food and Drug Administration (FDA) regulates tobacco products containing nicotine from any source, including synthetic nicotine.
The latest e-cigarette products use new chemical compounds such as Metatine and Imotine that claim to be exempt from regulations while delivering the same experience as nicotine (including addiction).
Attractive, but unsafe
Colorful packaging and flavors make the product attractive to young people. Their price is another selling point — they aren’t taxed like a regulated nicotine product, so they aren’t as expensive.
Their safety is far from assured, however. Vaping carries chemicals deep into the lungs, and e-cigarette use has been associated with lung injury and pneumonia. The aerosol in e-cigarettes can also contain cancer-causing chemicals.
The cravings that go along with nicotine addiction, and the irritability, sadness, sleeplessness, and inattentiveness associated with withdrawal, are other reasons to be wary of products that use compounds similar to nicotine as a selling point.
Specific dangers of long-term use of these new chemical compounds are not yet known, as they have only been on the market since late 2023. The young people these products target might not be in your workforce yet.
By the time they get there, the health effects of these chemicals may be clearer, and your smoking cessation program can help them make a decision that’s good for their health.